Alexander R. Giaquinto, Ph.D.

Head shot photo of Giaquinto.Career Profile: Dr. Giaquinto began his career in the pharmaceutical industry as a senior scientist with Vicks Division, Research and Development, Mount Vernon, New York. Over the years, he held many positions at Schering-Plough Corporation including senior vice president of Schering-Plough Research Institute. He was instrumental in establishing the development and regulatory strategies for the approvals of 74 NDAs, nine BLAs and 28 ANDAs and many Rx-to-OTC switch strategies. He was senior vice president for global compliance at Schering-Plough Corporation until his retirement in January 2004. He served as a member and chairman of the regulatory affairs coordinating committee of the Pharmaceutical Research and Manufacturers Association. He was one of the original members of the steering committee of the International Conference of Harmonization and served as one of the two U.S. pharmaceutical industry representatives from 1990 to 2003. While serving on this steering committee for ICH, he introduced the concept of the common technical document and served as co-chair of the Common Technical Document Implementation Coordination Group and the Global Cooperation Group. Dr. Giaquinto is a member of the American Association of Pharmaceutical Sciences, the American Society of Clinical Pharmacology and Therapeutics and the New York Academy of Sciences. He has lectured in food and drug law for Temple University’s graduate program in QA/RA. Dr. Giaquinto is a member of the board of directors for Biothera Holding Corporation and Biothera Pharmaceuticals Inc., both of Minneapolis. He has also held board positions with SemBioSys Genetics and Protox Therapeutics, both of Canada, and CannaPharmaRx of New Jersey.

Education: Dr. Giaquinto holds a B.Sc. in pharmacy from St. John’s University, Jamaica, Queens, and a Ph.D. in pharmaceutical medicine from the University of Connecticut.

Community involvement: Dr. Giaquinto spends most of his volunteer time with the Kessler Foundation, for which he was a board member, and with Children’s Specialized Hospital Foundation. He served as chairman of the board of Children’s Specialized Hospital Foundation for 13 years and has served on the hospital and foundation boards since 1989. In 2003, he was appointed a member of the board of trustees for Caldwell College, now university, and has served on the development and audit committees and as chairman of the board in 2009 and 2010.